These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4719916)

  • 21. Depot medroxyprogesterone acetate (Depo-Provera) as a contraceptive preparation.
    Bloch B
    S Afr Med J; 1971 Jul; 45(28):777-80. PubMed ID: 5106836
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparative use of 2 preparations of Depo Provera with semestral duration of action].
    Brat T
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):338-40. PubMed ID: 4681540
    [No Abstract]   [Full Text] [Related]  

  • 23. Reply to Dr. Edwin B. McDaniel. Exaggerated claims of depo-provera safety.
    Minkin SF
    Women Health; 1981; 6(1-2):125-9. PubMed ID: 6223451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experiences with Depo-Provera as a contraceptive agent].
    Kollstedt E; Sjöborg G
    Jordemodern; 1984; 97(1-2):18-20. PubMed ID: 6231273
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA board investigates Depo-Provera safety.
    Contracept Technol Update; 1983 Mar; 4(3):25-7. PubMed ID: 12266161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term contraception with Depo-Provera: a clinical evaluation.
    Mukherjea M; Mukherjee P; Biswas R
    Int J Fertil; 1980; 25(2):122-6. PubMed ID: 6117526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Premalignant dysplasias due to ovulation inhibitors?].
    Soost HJ
    Munch Med Wochenschr; 1972 Apr; 114(16):769-71. PubMed ID: 5067885
    [No Abstract]   [Full Text] [Related]  

  • 28. Controversy over Depo-Provera.
    Wash Drug Device Lett; 1977 Jan; 9(1):2. PubMed ID: 12335988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Premalignant dysplasias due to ovulation inhibitors?].
    Mestwerdt G
    Munch Med Wochenschr; 1972 Apr; 114(16):771-3. PubMed ID: 5067886
    [No Abstract]   [Full Text] [Related]  

  • 30. Depo-Provera use in an Australian metropolitan practice.
    Fraser IS; Dennerstein GJ
    Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Not FDA-approved, but experts recommend Depo-Provera.
    Contracept Technol Update; 1992 Jan; 13(1):1-7. PubMed ID: 12343458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depo-Provera -- proving its innocence.
    Choudhury IR
    Indian Med Trib; 1994 Jul; 2(11):5. PubMed ID: 12179187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depo-Provera highly effective as injectable contraceptive.
    Denniston GC
    Contracept Technol Update; 1985 Dec; 6(12):167-8. PubMed ID: 12280301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [An injectable progestestational hormone of long contraceptive duration: depo-provera, 150 and 400 mg].
    Simon P
    Bull Fed Soc Gynecol Obstet Lang Fr; 1969; 21(1):4-11. PubMed ID: 5383880
    [No Abstract]   [Full Text] [Related]  

  • 35. Contraceptive use--efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days.
    Schwallie PC; Assenzo JR
    Fertil Steril; 1973 May; 24(5):331-9. PubMed ID: 4698589
    [No Abstract]   [Full Text] [Related]  

  • 36. Depo-medroxyprogesterone acetate as a contraceptive.
    Seymour RJ; Powell LC
    Obstet Gynecol; 1970 Oct; 36(4):589-96. PubMed ID: 5506464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depo provera in perspective.
    McGoldrick IA
    P N G Med J; 1981 Dec; 24(4):274-9. PubMed ID: 6461984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Depo-Provera - an alternative contraceptive agent].
    Johansson E
    Lakartidningen; 1982 Aug; 79(34):2838-40. PubMed ID: 7144364
    [No Abstract]   [Full Text] [Related]  

  • 39. Frequent urination and Depo-Provera. Ask the experts.
    Kaunitz A; Nelson A; Wysocki S; Schnare S
    Contracept Technol Update; 1998 Dec; 19(12):160-1. PubMed ID: 12321808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDA advisory panel recommends approval for Depo-Provera.
    Contracept Technol Update; 1992 Oct; 13(10):159-60. PubMed ID: 12344726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.